{"transactions":[{"id":751665,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T21:23:15.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":162000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Scheduled to vest with respect to 25% of the shares on the one-year anniversary of the grant date, with the remaining shares scheduled to vest in twelve equivalent quarterly installments."}],"balance_after":162000,"derivative":{"exercise_price":5.84,"expiration_date":"2036-06-01","underlying":"Voting Common Shares","underlying_shares":162000},"source":{"system":"sec-edgar","filing":"0001490476-26-000002","document":"form4-06032026_090610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000149047626000002/form4-06032026_090610.xml","form_type":"4"}},{"id":1124801,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"officer":true,"officer_title":"CFO & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:16:00.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on June 1, 2026 with the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2026."}],"balance_after":225000,"derivative":{"exercise_price":4.11,"expiration_date":"2035-05-31","underlying":"Common Shares","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001437749-25-019290","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000143774925019290/rdgdoc.xml","form_type":"4"}},{"id":1495067,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:59:09.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on June 1, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2025."}],"balance_after":130000,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001235802-24-000052","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000123580224000052/primary_doc.xml","form_type":"4"}},{"id":1844176,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-06-26T20:21:11.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.91,"value":39100.0,"ownership":{"direct":true},"balance_after":32290,"source":{"system":"sec-edgar","filing":"0001235802-23-000070","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000123580223000070/primary_doc.xml","form_type":"4"}},{"id":1869724,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:46:23.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on June 1, 2024 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2024."}],"balance_after":67000,"derivative":{"exercise_price":2.73,"expiration_date":"2033-05-31","underlying":"Common Shares","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001235802-23-000062","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000123580223000062/primary_doc.xml","form_type":"4"}},{"id":2247453,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-02T21:02:32.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on June 1, 2023 and with respect to the remaining 75% of the underlying common shares in 36 as nearly equal as possible monthly installments commencing on July 1, 2023."}],"balance_after":60000,"derivative":{"exercise_price":2.45,"expiration_date":"2032-05-31","underlying":"Common Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001235802-22-000075","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000123580222000075/primary_doc.xml","form_type":"4"}},{"id":2602254,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Voting Common Shares, no par value per share","published_at":"2021-08-16T20:10:38.000Z","date":"2021-08-16","kind":"purchase","acquired":true,"shares":10000,"price":3.1463,"value":31463.0,"ownership":{"direct":true},"balance_after":22290,"source":{"system":"sec-edgar","filing":"0001235802-21-000097","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000123580221000097/primary_doc.xml","form_type":"4"}},{"id":2622115,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-30T01:02:54.000Z","date":"2021-07-28","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in sixteen nearly equal quarterly installments over four years."}],"balance_after":60000,"derivative":{"exercise_price":5,"expiration_date":"2031-07-27","underlying":"Common Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001235802-21-000091","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000123580221000091/primary_doc.xml","form_type":"4"}},{"id":2986482,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Voting Common Shares, no par value per share","published_at":"2020-11-10T13:16:48.000Z","date":"2020-11-09","kind":"purchase","acquired":true,"shares":2000,"price":4.1933,"value":8386.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $4.1824 to $4.21, inclusive.  The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":12290,"source":{"system":"sec-edgar","filing":"0001235802-20-000122","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000123580220000122/primary_doc.xml","form_type":"4"}},{"id":3126993,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-02T21:28:57.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in twelve nearly equal quarterly installments commencing on September 1, 2020."}],"balance_after":35000,"derivative":{"exercise_price":4.64,"expiration_date":"2030-05-31","underlying":"Common Shares","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001235802-20-000054","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000123580220000054/primary_doc.xml","form_type":"4"}},{"id":3434499,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Voting Common Shares, no par value per share","published_at":"2019-08-19T20:24:09.000Z","date":"2019-08-19","kind":"purchase","acquired":true,"shares":3000,"price":2.43,"value":7290.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $2.41 to $2.45, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":10290,"source":{"system":"sec-edgar","filing":"0001235802-19-000108","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000123580219000108/primary_doc.xml","form_type":"4"}},{"id":3478075,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-26T20:30:50.000Z","date":"2019-06-24","kind":"grant","acquired":true,"shares":99750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in eight nearly equal quarterly installments over two years."}],"balance_after":99750,"derivative":{"exercise_price":4.6,"expiration_date":"2029-06-23","underlying":"Common Shares","underlying_shares":99750},"source":{"system":"sec-edgar","filing":"0001235802-19-000062","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000123580219000062/primary_doc.xml","form_type":"4"}},{"id":3510278,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Voting Common Shares, no par value per share","published_at":"2019-05-28T11:17:19.000Z","date":"2019-05-24","kind":"purchase","acquired":true,"shares":4000,"price":2.9425,"value":11770.0,"ownership":{"direct":true},"balance_after":7290,"source":{"system":"sec-edgar","filing":"0001235802-19-000044","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000123580219000044/primary_doc.xml","form_type":"4"}},{"id":3735612,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Voting Common Shares, no par value per share","published_at":"2018-12-11T21:22:42.000Z","date":"2018-12-11","kind":"purchase","acquired":true,"shares":1250,"price":4,"value":5000.0,"ownership":{"direct":true},"balance_after":3290,"source":{"system":"sec-edgar","filing":"0001235802-18-000180","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1490476/000123580218000180/primary_doc.xml","form_type":"4"}},{"id":4024750,"issuer":{"id":11460,"kind":"organization","name":"Panbela Therapeutics, Inc.","symbol":"PBLA"},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-03-01T16:31:17.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":8.1,"exercise_date":"2018-02-27","expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-18-003651","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029125/000143774918003651/rdgdoc.xml","form_type":"4"}},{"id":4041080,"issuer":{"id":11460,"kind":"organization","name":"Panbela Therapeutics, Inc.","symbol":"PBLA"},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (right to buy)","published_at":"2018-02-22T17:28:38.000Z","date":"2018-02-20","kind":"purchase","acquired":true,"shares":1000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reported securities purchased as one share of common stock and one warrant to purchase one share of common stock for a combined price of $5.00 per \"unit.\""}],"balance_after":1000,"derivative":{"exercise_price":5,"exercise_date":"2018-02-20","expiration_date":"2021-02-20","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001437749-18-003127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029125/000143774918003127/rdgdoc.xml","form_type":"4"}},{"id":4041079,"issuer":{"id":11460,"kind":"organization","name":"Panbela Therapeutics, Inc.","symbol":"PBLA"},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-22T17:28:38.000Z","date":"2018-02-20","kind":"purchase","acquired":true,"shares":1000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reported securities purchased as one share of common stock and one warrant to purchase one share of common stock for a combined price of $5.00 per \"unit.\""}],"balance_after":4500,"source":{"system":"sec-edgar","filing":"0001437749-18-003127","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029125/000143774918003127/rdgdoc.xml","form_type":"4"}},{"id":4376691,"issuer":{"id":11460,"kind":"organization","name":"Panbela Therapeutics, Inc.","symbol":"PBLA"},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-03-21T17:11:40.000Z","date":"2017-03-17","kind":"grant","acquired":true,"shares":93000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 12, 2016, the reporting person was granted an option to purchase up to 300,000 shares of common stock.  The option became exercisable with respect to 66,000 shares as of December 12, 2016 and with respect to an additional 93,000 shares as of March 17, 2017.  The remainder is subject to vesting proportionately based on cash proceeds received by, or contractually obligated to be remitted to, the issuer after June 1, 2016 and before December 31, 2018 from any transaction, excluding certain internal operating-related cash flows."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Option vested with respect to 93,000 additional shares pursuant to certification by issuer compensation committee."}],"balance_after":159000,"derivative":{"exercise_price":1.51,"expiration_date":"2026-12-12","underlying":"Common Stock","underlying_shares":93000},"source":{"system":"sec-edgar","filing":"0001437749-17-005019","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029125/000143774917005019/rdgdoc.xml","form_type":"4"}},{"id":4522406,"issuer":{"id":11460,"kind":"organization","name":"Panbela Therapeutics, Inc.","symbol":"PBLA"},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-12-14T17:01:19.000Z","date":"2016-12-12","kind":"grant","acquired":true,"shares":66000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 12, 2016, the reporting person was granted an option to purchase up to 300,000 shares of common stock. The option vests proportionately based on cash proceeds received by, or contractually obligated to be remitted to, the issuer after June 1, 2016 and before December 31, 2018 from any transaction, excluding certain internal operating-related cash flows.  The performance criteria was 22% satisfied on the date of grant, resulting in vesting of the option as to 66,000 shares."}],"balance_after":66000,"derivative":{"exercise_price":1.51,"exercise_date":"2016-12-12","expiration_date":"2026-12-12","underlying":"Common Stock","underlying_shares":66000},"source":{"system":"sec-edgar","filing":"0001437749-16-043350","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029125/000143774916043350/rdgdoc.xml","form_type":"4"}},{"id":4522405,"issuer":{"id":11460,"kind":"organization","name":"Panbela Therapeutics, Inc.","symbol":"PBLA"},"owners":[{"id":41735,"kind":"person","name":"Kellen Scott","position":1,"cik":"0001490476","reported_name":"Kellen Scott","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-12-14T17:01:19.000Z","date":"2016-12-12","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options scheduled to vest in eight equal installments on the last day of each calendar quarter, starting March 31, 2017."}],"balance_after":150000,"derivative":{"exercise_price":1.51,"expiration_date":"2026-12-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-16-043350","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029125/000143774916043350/rdgdoc.xml","form_type":"4"}}]}